Studies with temocillin in a hamster model of antibiotic-associated colitis.

ESBLs: A Clear and Present Danger? Crit Care Res Pract (2011) 1.77

Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit. Eur J Clin Microbiol Infect Dis (2015) 0.75

BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans. Antimicrob Agents Chemother (1981) 8.81

Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect Immun (1981) 1.66

Evaluation of eight cephalosporins in hamster colitis model. Antimicrob Agents Chemother (1981) 1.35

Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother (1985) 3.19

Comparative effects of amoxycillin and ampicillin on the morphology of Escherichia coli in vivo and correlation with activity. Antimicrob Agents Chemother (1977) 1.59

Activity of amoxycillin/clavulanic acid against Escherichia coli in vivo--correction. J Antimicrob Chemother (1992) 1.39

Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383. J Antibiot (Tokyo) (1980) 1.39

Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections. Antimicrob Agents Chemother (1982) 1.37

Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis (1998) 1.34

Inaccurate haemoglobin estimation in Waldenström's macroglobulinaemia: unusual reaction with monomeric IgM paraprotein. J Clin Pathol (1993) 1.23

Antibacterial activity of ticarcillin in the presence of clavulanate potassium. Am J Med (1985) 1.21

Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chemother (1987) 1.19

Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey. J Antimicrob Chemother (2000) 0.95

Influence of clavulanic acid on the activity of amoxicillin against an experimental Streptococcus pneumoniae-Staphylococcus aureus mixed respiratory infection. Antimicrob Agents Chemother (1990) 0.93

Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo. Antimicrob Agents Chemother (1986) 0.89

Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice. Antimicrob Agents Chemother (1991) 0.88

Bactericidal effects of amoxycillin/clavulanic acid against a Legionella pneumophila pneumonia in the weanling rat. J Antimicrob Chemother (1991) 0.88

Lack of significant effect of therapeutic propranolol on measurable platelet function in healthy subjects. J Clin Pathol (1989) 0.88

Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection. J Antimicrob Chemother (1985) 0.88

Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections. Antimicrob Agents Chemother (1988) 0.86

Properties of MM 13902 and other carbapenem antibiotics in vitro and in vivo. J Antibiot (Tokyo) (1983) 0.85

Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats. Antimicrob Agents Chemother (1991) 0.84

Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials. Arch Virol (2003) 0.83

Staphylococcal osteomyelitis--a comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model. J Antimicrob Chemother (1994) 0.83

Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection. J Antimicrob Chemother (1994) 0.82

Acquired factor XI inhibitor in chronic lymphocytic leukaemia. J Clin Pathol (1992) 0.79

Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents. Antimicrob Agents Chemother (1995) 0.78

Synergy between ticarcillin/clavulanic acid and aminoglycosides against Pseudomonas aeruginosa infections in neutropenic mice. J Chemother (1989) 0.75

Combined therapy with co-amoxiclav and erythromycin against intracellular Legionella pneumophila in cell culture and in an experimental respiratory infection in neutropenic rats. J Antimicrob Chemother (1995) 0.75

Studies with temocillin in the hamster model of antibiotic-associated colitis. Drugs (1985) 0.75

Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection. J Antimicrob Chemother (1986) 0.75

Efficacy of co-amoxiclav compared with other beta-lactams, quinolones, tetracyclines and erythromycin against an experimental Chlamydia trachomatis respiratory infection. J Antimicrob Chemother (1993) 0.75

Comparative biological properties of some synthetic olivanic acid analogues. J Antibiot (Tokyo) (1983) 0.75